NCT03207880|Completed
Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services
Piloting an Innovation to Improve the Quality of Remote Abortion Services: Incorporating Use of Multi-Level Pregnancy Tests
Loading search results
Piloting an Innovation to Improve the Quality of Remote Abortion Services: Incorporating Use of Multi-Level Pregnancy Tests
Sponsor study identifier
interventional
165
1 country
1
Study Start
November 1, 2017
Actual (reported)Primary Completion
August 10, 2018
Actual (reported)Study Completion
August 10, 2018
Actual (reported)Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services through enabling women to reliably ascertain their abortion outcomes at home sooner than would otherwise have been the case. safe2choose provides remote medical abortion services through the Internet (information, counselling and access to abortion pills) in a growing number of countries worldwide. safe2choose will collaborate with Gynuity Health Projects to pilot the utility of MLPTs for home follow-up as part of its remote medical abortion services. As safe2choose does not have a physical office, the location of the sponsor's office is listed in this entry as the study location. Women from the United States are NOT eligible to enroll.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 10, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 30, 2017
Actual (reported)July 5, 2017
Actual (reported)November 1, 2017
Actual (reported)August 10, 2018
Actual (reported)August 10, 2018
Actual (reported)Proportion of women who successfully receive the MLPTs
1 week after mailing the MLPTs
Proportion of women who use the MLPTs to determine their abortion outcome
2 weeks after receiving medical abortion package
Proportion of women able to use MLPTs on their own without guidance or instruction from providers
2 weeks after receiving medical abortion package
Proportion of women who take action based on the interpretation of their test results
2 weeks after receiving medical abortion package
Proportion of women who are satisfied with using MLPTs
2 weeks after receiving medical abortion package
Proportion of all eligible safe2choose clients who elect to participate in the study
0 days after recruitment
Proportion of women who find the MLPT instructions (written and video) to be helpful tools
2 weeks after enrollment
Multi-level pregnancy test
Study participants will be instructed to perform a baseline MLPT immediately prior to administering the first dose of abortion medication and a second MLPT one week later to ascertain the follow-up hCG range. Any woman who obtains a stable or increasing hCG result, when comparing the baseline test result with the follow-up test result, will be instructed to contact safe2choose. Any woman who obtains a decrease in her hCG range, when comparing the baseline test result with the follow-up test result, will be informed that her abortion was a success and she is no longer pregnant.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Gynuity Health Projects
New York, New York, 10010, United States
Erica Chong, MPH
Gynuity Health Projects
Jennifer Blum, MPH
Gynuity Health Projects
Beverly Winikoff, MD, MPH
Gynuity Health Projects
165 participants (actual enrollment reported by the registry).
First Submitted
June 30, 2017
First Posted
July 5, 2017
Study Start
November 1, 2017
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
August 10, 2018
Actual (reported)Study Completion
August 10, 2018
Actual (reported)Last Updated
September 27, 2018
Record last verified: 2018-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: